ORMP Competitors
Oramed Pharmaceuticals Inc.
$4.07
-$0.11(-2.63%)
50
Overall
80
Value
27
Tech
44
Quality
Market Cap
$169.30M
Volume
277.08K
52W Range
$2.09 - $5.47
Target Price
$7.00
ORMP competitors: RARE, CGEN, SNY, NVO, LXRX. Oramed Pharmaceuticals Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
ORMP Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical Inc. | $14.54 | $1.43B | $-3.95 | - | 33 |
| CGEN Compugen Ltd. | $1.96 | $185.39M | $-0.28 | - | 54 |
| SNY Sanofi | $40.61 | $99.04B | $5.00 | 5.96% | 66 |
| NVO Novo Nordisk A/S | $38.83 | $171.94B | $3.53 | 4.77% | 56 |
| LXRX Lexicon Pharmaceuticals, Inc. | $1.52 | $676.33M | $-0.17 | - | 41 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ORMP | $4.07 | -2.6% | 277.08K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Oramed Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW